Breaking News on Drug Discovery

All our newsletters Free Newsletter   OK




Search
  OK
 since



News Headlines
 Emerging targets
Tools and techniques
Research management

All news articles

May 2008
April 2008
Previous months

Products & Markets

Product & Supplier News
Product Innovations
Supplier Info Centres
Market Reports
Events

Business Tools

Free Newsletters
All Newsletters
All Sites
News Syndication



Free Newsletter

 OK
All newsletters






Newsletter archives   Pharmaceutical & Cosmetic
Homepage



 Daily newsletter / Weekly newsletter

January 2008
 02/01 Iraq fraud/Lung cancer/brain tumours/Sanofi-Aventis & IDM Pharma/MPI Research Read this newsletter

December 2007
 20/12 Phase I/Pfizer & CovX/biochips/drug for athletes/Embryome Sciences Read this newsletter
 18/12 NIH microbiome/OGeS & Amgen/Affymetrix/CROs merge/Phase I/ Read this newsletter
 17/12 HIV/Shire & Alba/Curiox Biosystems/Tamiflu/cell line Read this newsletter
 13/12 Biogen Idec/Merck & Co/HDAC inhibitors/Biowa & Lonza/Mini synchrotron Read this newsletter
 11/12 GSK & OncoMed/Roche & Ventana/Carl Zeiss/CRO merger/Eisai buys MGI Read this newsletter
 10/12 Eisai buys MGI/Galapagos & GSK/ NMR software/BMS job cuts/Morphosys and Novartis Read this newsletter
 06/12 BMS job cuts/morphosys and novartis/microfluidics/NMR/drugs in the clinic Read this newsletter
 04/12 Addex Merck/Glenmark/Pfizer/drugs/Regeneron Read this newsletter
 03/12 Sanofi Regeneron/Pfizer offshoring/Jubilant Organosys/Technology Pioneers/Astellas Read this newsletter

November 2007
 27/11 Astellas & Agensys/ERC funding/nano-flares/Xenome & Amylin/GVK Bio/ Read this newsletter
 26/11 Targeted Genetics/Paediatric drugs/bioluminescence/Outsourcing/preclinical round up Read this newsletter
 22/11 Immune system brakes/Mr Gene/CRO/Merck & Co, Vertex/Phase I Read this newsletter
 21/11 Embyro free stem cells/Cisbio/Covance/evolution/GTx male contraceptive Read this newsletter
 20/11 Merck & Co/Alzheimer's/vaccine market/Randox/Raven Biotechnologies/ Read this newsletter
 19/11 Celgene & Pharmion/Pfizer & Coley/Russia biologics/Caliper/Genzyme Read this newsletter
 11/15 Stem cells/Icahn & Genzyme/Lupus/Preclinical round up/Phase I Read this newsletter
 14/11 Roche Ventana/Accelrys/Evotec/AZ in trouble/Smac Read this newsletter
 13/11 AstraZeneca/Smac cancer/Nanogen/ABI & BioTrove/Drug safety model/ Read this newsletter
 12/11 Drug safety model & Merck/WHO/Tripos/ShangPharma/BAC Read this newsletter
 08/11 Merck HIV vaccine/Aveo/Amgen/NanoImaging/Phase I Read this newsletter
 07/11 Biomarker market/Merck & GTx/AstraZeneca/preclinical round up/Sanofi Pasteur/ Read this newsletter
 06/11 Apitope/Pfizer torcetrapib/MS genotyping/Charles River/Tecan & GE Read this newsletter
 05/11 Eli Lilly/BioInvent & ThromboGenics/opium crops/Sigma-Aldrich/Pharma must reinvent/ Read this newsletter
 01/11 Cancer virus/tractor beam/GSK/Gene Logic/Nikon/ Read this newsletter

October 2007
 31/10 Parkinson's/spectroscopy/Covance/Nycomed & Bradley/Phase I/ Read this newsletter
 10/30 Big pharma & Summit/Roche/Takeda/Thermo/antibiotics Read this newsletter
 29/10 Big pharma's helping hand/gene therapy/protein abundance/Arthur Kornberg/cancer innovation Read this newsletter
 23/10 Cancer showcase/Screening nature/Alzheimer's genes/GSK outsource/cholesterol/ Read this newsletter
 25/10 GSK cuts/Sanofi-Aventis slammed/Illumina/personalised medicine/Phase I Read this newsletter
 24/10 California fires/J&J, Galapagos/Pfizer/microfluidics/Merck KGaA Read this newsletter
 23/10 Kirin & Kyowa/HSP90 drugs/Illumina/Sigma-Aldrich/Preclinical round-up Read this newsletter
 22/10 Sugar-free neurons/Viagra/EU regs/Promega/Exubera Read this newsletter
 19/10 Rat toxicology/diabetes/animal testing/aspirin for men/pharma social networking/ Read this newsletter
 18/10 Pfizer bins Exubera/Novartis/BioXell/Agilent & BioTrove/services database Read this newsletter
 17/10 HIV evolution/Foot-tapping/BMS/Asia preclinical testing/Epicept/ Read this newsletter
 16/10 Boehringer Ingelheim & Vitae/Wyeth/Orexo & Biolipox/Roche/Galapagos/ Read this newsletter
 15/10 Biogen Idec/PCR/GSK/saving drug costs/Moodys/ Read this newsletter
 12/10 Obesity/best bosses/Ventana/NanoDrop/Phase I Read this newsletter
 11/10 Wyeth & Zealand/GSK & Synta/Ablynx IPO/Cell-free protein synthesis/Kinaxo Read this newsletter
 10/10 Novartis & Speedel/RBM & EDI/NPS Pharmaceuticals/China/GSK/ Read this newsletter
 09/10 GSK/Pfizer & Sanofi/3D cell cultures/immune system model/BioProcessors/ Read this newsletter
 08/10 Nobel prize/Sainsbury report/R&D spending/Novartis/Clinical staffing Read this newsletter
 05/10 Pfizer's biotech baby/Horiba/Chilli pain/R&D round up/Phase I Read this newsletter
 04/10 'Extreme PMT'/stem cells/Bayer & Biocon/Eli Lilly/PDL stock Read this newsletter
 10/03 Tamiflu/PDL BioPharma/BMS/gel contraceptive/Recordati Read this newsletter
 02/10 Biogen Idec/Drug safety/BMS/ABI & Olink/In-house outsourcing Read this newsletter
 01/10 Synta/Trop-2/Pfizer/Novartis/DPP-4 inhibitor Read this newsletter

September 2007
 27/09 AZ/GSK/stem cells/Japan drug lag/Phase I Read this newsletter
 26/09 schizophrenia target/Merck Crucell/IOTA/ADME-Tox assay/Wyatt Tech Read this newsletter
 25/09 BMS Adnexus/India innovation/membrane biology/ProImmune/Merck HIV Read this newsletter
 24/09 Merck HIV/Sanofi cancer/Pfizer Japan/personalised medicine/cell scaffold Read this newsletter
 20/09 Oxford Genome Sciences/3D cell scaffold/ReachBio/R&D round-up/Phase I Read this newsletter
 19/09 Evotec/Sanofi-Aventis pipeline/Arcxis/Provectus/Preclinical news Read this newsletter
 18/09 cancer funding/Sanofi-aventis/tRNA inhibitors/tracing proteins/Microbia & Forest Read this newsletter
 17/09 cheap drugs/Caliper LS/Pharmacopeia/genomic standards/BioReliance Read this newsletter
 13/09 Eurostars/Novartis/Celsis/ZS Genetics/Loneliness Read this newsletter
 12/09 F-star/Cellectricon/Marksman Cellject/Outsourcing/Phase I Read this newsletter
 11/09 Merck & Co/AZ & Biovator/BioVascular & Revitus/Imaging/Biogen Idec Read this newsletter
 10/09 Ablynx/Isis & Alnylam/Cisbio/King & Palatin/Merck & Co. Read this newsletter
 06/09 hybrid embryo/cancer approvals/Isis/ChemGate/Evotec Read this newsletter
 05/09 Isis diabetes/IonGate LIVC/AZ China/Serenex/Millipore Read this newsletter
 04/09 Serenex/Zebrafish/arthritis model/Eli Lilly/Entelos Read this newsletter
 03/09 Eli Lilly/Entelos Iconix/outsourcing to Asia/Micromet/RNAi screening Read this newsletter

August 2007
 30/08 Micromet/LAB & Charles River/Sigma-Aldrich/fear of failure/Vioxx Read this newsletter
 29/08 Vioxx/Sangamo/CRO survey/Proteomics data/Phase I Read this newsletter
 28/08 Arpida/toxicity/Nicholas Piramel/MicroCal/R&D round up/ Read this newsletter
 23/08 Merck KGaA/Pfizer/Amgen IL-17/Novartis/Phase I/ Read this newsletter
 22/08 Biogen Idec/Merck-Frosst/Domainex/Bayer/Amgen/ Read this newsletter
 21/08 Bayer/Amgen/Phase I rules/Applied Biosystems/Pfizer/ Read this newsletter
 16/08 Pfizer/Actelion/Amgen/Agilent/No lack of innovation Read this newsletter
 14/08 No lack of innovation/3D cell image/MS vaccine/Antibody rival/wish list Read this newsletter
 13/08 Big pharma wish list/Invitrogen/Phase I/preclinical news in brief/Pfizer Read this newsletter
 09/08 Merck and Neuromed/Jeol NMR/PerkinElmer HCS/Charles River/Nanotherapeutics Read this newsletter
 08/08 Archemix alliance/Abraxis discovery/Galapagos/new glaucoma target/ChanTest Read this newsletter
 07/08 new glaucoma target/ChanTest ion channel/discovery services/Pfizer's GORD/Entelos FDA model Read this newsletter
 06/08 Pfizer's GORD/Entelos FDA model/PharmaNet/Asuragen miRNA/HIV breakthrough Read this newsletter
 02/08 HIV breakthrough/Merck & Co/MDS Pharma/GSK personalised medicine/PADI/ Read this newsletter
 01/08 Johnson & Johnson/trial death/structure recognition/Tepnel/Phase I/ Read this newsletter

July 2007
 31/07 BioWa/Novogen/Medivation/Nikon/Xceleron/ Read this newsletter
 30/07 GSK & Targacept/AZ & BMS/Aperio/animal testing/Phase I Read this newsletter
 26/07 Panacos HIV/SwitchGear/Covance/Cell Therapeutics/Benitec Read this newsletter
 25/07 Cell Therapeutics/genotoxicity assay/Benitecs RNA/WuXi IPO/AIDS expo Read this newsletter
 24/07 AIDS expo/MedImmune asthma/ABI miRNA/biosimilars/oral release Read this newsletter
 23/07 Schering-Plough/cellular asays/PETA honours Novozymes/MS drug stalls/new asthma target Read this newsletter
 19/07 asthma target/luminex assay/Pfizer externalisation/antibody/miRNA Read this newsletter
 07/18 Fresenius antibody/miRNA discovery/Acambis/Evotec/slow year/ Read this newsletter
 07/17 slow year/stretching DNA/Asia PhaseI/ITS/Kinaxo Read this newsletter
 07/16 flu vaccine/drug-protein assay/trials leave US/blood-brain-barrier/cell culture Read this newsletter
 07/12 stem cell/Ventana-Roche/DNA purifier/preclinical/viral tumour killer Read this newsletter
 07/11 viral tumour killer/zinc finger/cancer vaccine/execution/anticalin Read this newsletter
 07/10 Roche/binding affinity/Covance/GLIS2/Pfizer Read this newsletter
 07/09 AZ & Roche/Hunter-Fleming/NanoBioDesign/death penalty/Novo Nordisk Read this newsletter
 05/07 Parkinson's/Lundbeck/Lexixon/Illumina/Phase I/ Read this newsletter
 04/07 P&G deal/Anthera/Peptide adhension/AZ & BioWisdom/trial participation/ Read this newsletter
 03/07 Mini-antibodies/NicOx/Pharmanet/Amaxa/Immunoassays/ Read this newsletter
 02/07 nut allergy/Invitrogen/Intercell/Vastox/Teva/ Read this newsletter

June 2007
 28/06 Teva allergy/HIV protection/biosensor/Waters/Aptuit Laurus/ Read this newsletter
 27/06 Nuvelo & Bayer/BMS AZ/CellASIC/Phase I/Asterand/ Read this newsletter
 26/06 FRAME/Virtual cell/Roche/preclinical services/arthritis Read this newsletter
 25/06 Roche/Anacor/Genzyme/tumour supressors/Parexel & Tegenero Read this newsletter
 21/06 gene mutation/drugs/metabolomics/Thermo/Fluidigm Read this newsletter
 20/06 Stem cell fate/neurology/Russia ban lifted/Fairfield/EU US bonding/ Read this newsletter
 19/06 Bayer/Diamyd/Teva/breast cancer/PINK Parkinson's/ Read this newsletter
 14/06 GSK mystery/Biovest/Phase I/ThalesNano/Nicholas Piramal/ Read this newsletter
 13/06 Alzheimer's/Cancer pathways/Pfizer/Death sentence appeal/melting DNA/ Read this newsletter
 12/06 GSK/Coley 3M/Kinase SARfari/Merck & Archemix/Asterand Read this newsletter
 11/06 ASCO roundup/Parkinson's breakthrough/Agilent/gene therapy/biologial ban Read this newsletter
 07/06 HIV/AMT/obesity/electronic labbook/biologial ban Read this newsletter
 06/06 Merck/Oxigene/Phase I/nanodots/trial registration Read this newsletter
 05/06 Parkinsons/Phase I design/Phase 0/Thermo Fisher/deltaDOT Read this newsletter
 04/06 Wyeth/Free drugs/image analysis/ASCO/Alzheimers Read this newsletter

May 2007
 31/05 Rexahn/Bird flu/ADInstruments/drugs/systems biology Read this newsletter
 30/05 Avalon/Ethics/personalised medicine/AstraZeneca/Merck/ Read this newsletter
 29/05 Increased intelligence/China/Proteomics/GSK/Shantha Biotechnics/ Read this newsletter
 24/05 Exelixis/Malaria vaccine/cell imaging/Genzyme/Phase I/ Read this newsletter
 23/05 mini-antibodies/EpiStem/Research alliance/Alzheimer's/IMI/ Read this newsletter
 22/05 Alzheimer's/EU initiative/ubiquitin/ArrayJet/Roche/ Read this newsletter
 21/05 MRSA/BioLineRX/mouse model/Evotec/microRNA mechanism/ Read this newsletter
 17/05 microRNA mechanism/ion channels/protein kinase C/Imaging/animal experiments/ Read this newsletter
 16/05 DNA damage/RNAi cancer/outsourcing R&D/HIV test/Phase I/ Read this newsletter
 15/05 cancer stem cells/vasculitis/cell migration/Biomolecule separation/preclinical Read this newsletter
 10/05 Dendreon/BMS & Isis/Charles River/preclinical to clinic/Novartis Read this newsletter
 09/05 Novartis/critical residues/Parkinson's/innovation/micro-channels Read this newsletter
 08/05 Huntington's/Genaera/Genta/microfluidics/Kendle Read this newsletter
 03/05 Covance GSK/Xceleron/Zorro-LNA/Outsourcing/Phase I drugs Read this newsletter
 02/05 Zorro-LNA/animal rights extremists/GSK Wellcome Trust/Phase I drugs/pressure cycling/ Read this newsletter

April 2007
 30/04 Antibacterials/Pfizer/melanoma/weighing cells/clinical outsourcing/ Read this newsletter
 26/04 Solvay/B cells/microwaves/online proteome/biogenerics/ Read this newsletter
 25/04 Pfizer/cardiac profile/gene repair/antismoking vaccine/Systems biology/ Read this newsletter
 24/04 Systems biology/Addex/Jeol/Biocon/preclinic to clinic/ Read this newsletter
 23/04 BioFocus/Novartis/baby steps/leukaemia/industry awards Read this newsletter
 18/04 ReNeuron/cell migration/primate research/Vertex/pressure Read this newsletter
 17/04 Vertex/pressure/deltaDOT/drug safety/UPT Read this newsletter
 16/04 GSK/fertility/Galapagos/venom/pharma Read this newsletter
 12/04 venom/attention seeking/agilent/Climate change/preclinical/ Read this newsletter
 11/04 stem cell diabetes/multiple sclerosis/athersclerosis/Galapagos/cell cardiogram/ Read this newsletter
 10/04 diabetes/stem cell patent/GSK & Adolor/biosensor/preclinical/ Read this newsletter
 04/04 Neopharm/Nonlinear Dynamics/bio-sugars/Japan/Phase I/ Read this newsletter
 02/04 Evotec/Roche/Covance/GSK & Ranbaxy/Senscence Read this newsletter

March 2007
 30/03 Sanofi/clinical safety/Merck/stem cell tracker/Phase I Read this newsletter
 28/03 Torcetrapib/antisense/Charles River/marked tumours/leukaemia Read this newsletter
 26/03 Targeting cancer/leukaemia/Eisai/Biocon/preclinical to clincal/ Read this newsletter
 23/03 Eisai/Amicus/preclinical to clincal/clinical software/budget/ Read this newsletter
 22/03 Japan/natural drugs/innovation/kinase/GSK/ Read this newsletter
 20/03 AtheroGenics/IBD/Sony PS3/Baxter/Alexion/ Read this newsletter
 16/03 Eli Lilly/Tykerb/Millipore/BMS in India/Thermo/ Read this newsletter
 14/03 Schering-Plough/precancerous stem cells/report/schering-plough/GSK/ Read this newsletter
 12/03 Schering-Plough/GSK/bacteria/stem cells/preclinical/ Read this newsletter
 09/03 NSAIDs/stem cells/sleeping sickness/cancer genome/Frontier Read this newsletter
 07/03 Hypertension/HIV/Bio-Rad/online RNA/preclinical to clinic Read this newsletter
 05/03 Novo/GSK/PPD & Ranbaxy/bacteria genome/Labcyte/ Read this newsletter
 02/03 Bayer & Abbott/industry funded trials/radiotherapy/Galapagos/animal testing Read this newsletter

February 2007
 28/02 Animal research/stroke/preclinical/Down's syndrome/Alzheimer's Read this newsletter
 26/02 Down's syndrome/Alzheimer's/healthcare awards/influenza/FDA Read this newsletter
 23/02 influenza/FDA funding/Novartis/cell mating/biosensor Read this newsletter
 21/02 OFT report/BTG/India/breast cancer/schizophrenia/ Read this newsletter
 19/02 Pharmacopeia/obesity/cancer/funding shortage/preclinical Read this newsletter
 16/02 DNA microarray/Materia catalysts/Lpath/Invitrogen/Drugs into the clinic Read this newsletter
 14/02 beta proteins/Sanofi-Aventis/Thrombogenics/biomarkers/Albany Read this newsletter
 12/02 Diabetessystems biologyearly clinical phaseanti-agingpsoriasis Read this newsletter
 09/02 HIV/nano-imaging/pre-clinical to clinic/microsieve/Roche Read this newsletter
 07/02 RocheWyethAstraZenecaPreclinicalRNAi Read this newsletter
 05/02 RNAi/polonium/Bridge/AstraZeneca/predicting successful drugs Read this newsletter
 02/02 AstraZeneca/Pfizer/predicting successful drugs/Thermo fisher/MorphoSys Read this newsletter

January 2007
 31/01 Sanofi-Aventis BMS/blood vessel growth/Covance/Preclinical to clinic/Northwick Read this newsletter
 29/01 Northwick trial/antibiotic resistance/Robotics/obesity/cancer Read this newsletter
 26/01 Obesity/Smoking/Coley/Genetic mutations/weak RNA Read this newsletter
 24/01 Tumour sensitivity/Pfizer/Carbon Monoxide/Bruker/Animal rights Read this newsletter
 22/01 RNA cancer therapy/bacteria drug delivery/Cellartis/AstraZeneca/EU funding Read this newsletter
 19/01 19/01 'Trojan Horse' vaccines/Malaria drug/Chemical weapons vaccine/HIV drug resistance/Bayer VTT Read this newsletter
 17/01 Pfizer/Novo Nordisk/Tocris Bioscience MBO/BG, Applied Biosystems/ReNeuron stem cell Read this newsletter
 15/01 Obesity Drug/Parkinson's & cholesterol/Microlab/Radiation Syndrome/BioIT Alliance Read this newsletter
 12/01 AstraZeneca & Bristol-Myers Squibb/Protein 'atlas'/Stem cells/Predicting proteomics/Drugs into clinic Read this newsletter
 10/01 Stem cells/Genentech/Synosis&Roche/Cancer vaccine/virtual clinical trials Read this newsletter
 08/01 Janssen, Invega/Genentech, Roche/amniotic, stem cells/Tufts/Ecopia, Caprion Read this newsletter
 05/01 Nanotech breakthroughs/Pfizer MRSA/Painless living/Amgen & Galapagos/Preclinical to clinical drugs Read this newsletter
 03/01 GAO, FDA/Neural stem cells, metastatic cancer/Telik, Telcyta/Alzheimer's, Siemens/ Tripos, Provid Read this newsletter

December 2006
 21/12 Best of DrugResearch for December 2006 Read this newsletter
 20/12 GSK Genmab/Diabetes cure/polo kinase/fluidigm & digital PCR/Bridge & Gene Logic Read this newsletter
 18/12 Antisense Genta/University of Leeds/ValiRx Morphogenesis/MDS FDA/FDA Read this newsletter
 15/12 Alk-Abello & hayfever/Boehringer Ingelheim/conflict of interest/Genentech & AC Immune/AQIX Read this newsletter
 13/12 GSK, EPIX/primate medical research/Merck, Zocor/Bayer, Nuvelo/Cooksey Read this newsletter
 11/12 Sunderland/Biophage, biosensor/stem cell, stroke/tax credits/R&D/FDA Read this newsletter
 08/12 Duff, teGenero/GSK, GM bacteria/Onyx/Galapagos Read this newsletter
 06/12 NIH, Pfizer/gene therapy, erectile dysfunction/Roche, University of Basel/Intertek, Alta Read this newsletter
 04/12 Torcetrapib/Evotec/personalised medicine/lipidomics/cancer Read this newsletter
 01/12 Gene expression/Tripos/Latin America/UK trials/Heart regeneration Read this newsletter

November 2006
 29/11 Stem cells/Amyloid/Immunotherapy/LIMS/cell preserver Read this newsletter
 27/11 Kidney research/breast cancer/cystic fibrosis/dyslipidaemia drug/NMR assays Read this newsletter
 24/11 Dyslipidemia/NMR assay/Hepatitis C/R&D offshoring/PharmaNet lawsuit Read this newsletter
 22/11 Diabetes, prize winners/PETA, Pfizer/Merck, India/Covance, testing/Singapore, Pharma Read this newsletter
 20/11 Merck/Chi-Med/SARS/Seattle Genetics/Bayer/eClinical Read this newsletter
 17/11 Animal activists/Thyroid cancer/PETA, Eli Lilly/Metabolex, EU patent/Accelrys, software Read this newsletter
 15/11 Big Pharma, Doha declaration/Painkillers, snails/Oxoid/Oxford Biomedica/Nautilus, Creabilis Read this newsletter
 13/11 Coalition/animal testing/Waters /Advion/ESA/ HPLC/Charles River/Dendrite Read this newsletter
 10/11 CRO/Wyeth, Ablynx/Asterand/NIH/Bioprocessing Read this newsletter
 08/11 Ambit, Cephalon/Blockbusters, niche/Tecan/VirtualScopics/Novartis Read this newsletter
 06/11 Cystic Fibrosis/Ground Zero Pharma/Isogenica/IntegraGen/ProImmune Read this newsletter
 03/11 Genetic, qRT-PCR/Cyanide/RNase, DNase/Millipore/Galapagos Read this newsletter
 02/11 Galapagos, LEO pharma/FDA, microdosing/Datatrak/Argos Therapeutics/WHO, XDR-TB Read this newsletter
 01/11 WHO, XDR-TB/Sigma Aldrich/Roche, hep C/bacteria, anti-cancer drugs/Qiagen, Genaco Read this newsletter

October 2006
 31/10 Qiagen, Genaco/Genetic sequence/Datatrak/BioWa, Mab/Enzyme, Alzheimer Read this newsletter
 27/10 Enzyme / Alzheimer's/Aurora B/Qiagen / PCR/Cleveland BioLabs/Thermo Electron Read this newsletter
 26/10 Thermo Electron/China / Outsourcing/Pharma / R&D/MDS Pharma/EU cardiovascular drug Read this newsletter
 25/10 CV drug market/Charles River Labs/Fisher Scientific/GSK/Biochip Read this newsletter
 24/10 Biochip/imaging probe/PPD, Q3/enzyme tumourgenesis/DNA methylation Read this newsletter
 20/10 Applied Biosystems/Mettler Toledo/Pakistan Pharma industry/Quintiles/Agilent Technologies Read this newsletter
 19/10 Agilent Technology/Covance/Rohm and Haas/PDI, GSK/Wyeth, Genedata Read this newsletter
 18/10 Wyeth Pharma, Genedata/Applied Biosystems/Lexicon Genetics/Parexel/Sugar compound, Seizures Read this newsletter
 17/10 Sugar, Seizures/Millipore, GPCR/ClinTec, Dr.Reddy/DNA-based computers/Integrated protocols Read this newsletter
 13/10 Integrated exploratory protocols/IT streamlining/Tecan/Holmes Biopharma/India's top 100 Read this newsletter
 11/10 Pharma outsourcing/PerkinElmer/data warehouse/early phase studies/data track Read this newsletter
 09/10 Kinase market/BioDiscovery/Tumour Suppressor gene/UCB, Prosonix/Top locations Read this newsletter
 06/10 Bird Flu/GTC, LFB/Heat-on blocks/FDA, Drug safety/Agilent, Distek Read this newsletter
 04/10 Antibiotic, cancer/PainCeptor/Mobious, prototype/EU Commission/Oncology testing Read this newsletter
 02/10 Search engine/malaria/TTP LabTech/Aptuit/GlaxoSmithKline Read this newsletter

September 2006
 29/09 Virtual Model/Flesh eating/Illumina/India, self regulation/Nastech, bird flu Read this newsletter
 27/09 CRO/MRSA/Diabetes/Nanotechnology/TandemLabs Read this newsletter
 25/09 CRO, contribution/Telomerase, target/Early phase/Thermo, pipette/Mirus Bio, RNAi Read this newsletter
 22/09 Merck, Serono/Chembridge, AstraZeneca/Avidia, Crohn's/Enzyme, R&D/Indian trials, ethics Read this newsletter
 20/09 Pfizer, TransTech/Dual-role protein/High Content Screening/IT outsourcing/India, Clinical research Read this newsletter
 18/09 Bristol Myers Squibb/Akubio/Zeiss/Diabetes coalition/Biomarker, cancer Read this newsletter
 15/09 Genomics/CRO/method/sieve/Xceleron Read this newsletter
 13/09 Antibiotic resistance/Eli Lilly/Amphora/Spectrometer/Tuberculosis Read this newsletter
 11/09 TB super strain/Cranberry / UTI/GSK / ChemoCentryx/Synexus / India/Synexus / India Read this newsletter
 08/09 R&D outsourcing/New drug class, cancer/Asia, Outsourcing/Clinical trials, accountability/Invitrogen, reagent Read this newsletter
 06/09 Chemokine, patent/Screening method/Dalton, chemistry services/Method, drug modification/Tripos, software Read this newsletter
 04/09 Method, drug modification/Tripos, software/SFBC, PharmaNet/Eli Lilly, Suven/Pharsight Read this newsletter
 01/09 Eli Lilly, Suven/Pharsight/Bacteria, new drugs/Caliper, in-vivo/PerkinElmer, chromatography Read this newsletter

August 2006
 30/08 PerkinElmer, Gas Chromatography/Nastech, siRNA/Receptors, anthrax/US enzyme demand/Protein, Bowel disease treatments Read this newsletter
 25/08 protein, bowel disorders/Evotec, CHDI/Peakdale, Kinase/Charles River Labs/Animal behaviour automation Read this newsletter
 23/08 Animal behaviour/Staphylococcus aureus/Lung cancer, test/Wanted: Journalists/Argos, immunotherapy Read this newsletter
 21/08 Argos, pharmacogenomics/Alantos, diabetes/HIV, immune cells/Bionas, cell monitoring/Ariad, mTOR Read this newsletter
 18/08 Ariad, Cancer drug patent/Market research, early phase/Bio-Rad, Ciphergen/Nexcelom, cell counter/Covance, animal activists Read this newsletter
 16/08 Covance/Biogen/varian/microscope/AM-Pharma Read this newsletter
 14/08 AM Pharma, Lactoferrin/New HIV drug/Guava Technologies, antibody screening/Millipore, TTF/Animal-human embryonic hybrids Read this newsletter
 11/08 Animal-Human hybrids/IDBS, In Silico/In-vitro genotoxicity/Campbell brothers/autoimmune disease Read this newsletter
 09/08 Autoimmune disease/Aviva/DNA target gene/natural antimicrobials/Pharma, carbon growth Read this newsletter
 07/08 Multiple Sclerosis/Nanogen, Fisher Scientific/Thermo, microcentrifuge/GSK, Expression Analysis/Clinical trials, Finder's fee Read this newsletter
 04/08 Mushroom, cancer drugs/SuperArray, PCR/Aldevron, GIA/FDA, conflict/Tumour suppressor Read this newsletter
 02/08 CDHI, Edison/Chimatica, screening/Predix, Amgen/Animal extremists/FDA Read this newsletter

July 2006
 31/07 Parkinson's, model/Murex, Ariadne/Diabetes, market growth/Report, clincal trials/Drug delivery, partnerships Read this newsletter
 28/07 Locus, drug resistance/Avalon, ChemDiv/Nano Probe/Genentech, Inotek/FDA, Clinical trials Read this newsletter
 26/07 New concept, Screening/SCS, stem-cell/HCV, CE mark/FDA, trial fraud/Omnia Biologics, TB Read this newsletter
 24/07 Real-time tool/Tyrosine Kinase receptor/genetic code, drug discovery/Prostate cancer/Rentschler, antibody Read this newsletter
 21/07 HIV / resistance/Worm / screening/Alnylam / siRNA/Haemorrhoids / strain/Galapagos / Cellzome Read this newsletter
 19/07 Haemorrhoid, treatment/Galapagos, Cellzome/Mass spectroscopy/Crystallisation/Agilent, Microarray Read this newsletter
 17/07 Neuropharma, Alzheimer's Disease/Archemix, Elan/Torey Pines /MedImmune, Flumist/Novartis, Maryland Read this newsletter
 14/07 HIV, 3-in-one/AERYx, GI drug/NIAID, software/Ohaus, balances/Frost and Sullivan, awards Read this newsletter
 12/07 Hybrid, genomic sequencing/Imaging, pharmacogenomics/Locus, Ono/MorphoSys, HuCAL/Thermo, Pipetting Read this newsletter
 10/07 TSG mutation/Isotechnika, patent/Wyeth Novascreen/Speedel, PiperJaffray/Dynal, immunotherapy Read this newsletter
 07/07 Speedel pipeline/Dynal, immunotherapy/Asterand, human tissue/Adjuvantix, AIDS/Merck, cyanide Read this newsletter
 05/07 Baraclude, EU approval/ExonHit, RNA splicing/DanioLabs, Parkinsons/FDA approval, Chi-Med/Tripos, Software Read this newsletter
 04/07 ChemGenex, MolecularMD/ESF, EuroBioFund/Applied Biosystems, DNA/staff costs, pharma/checklist, CRO's Read this newsletter

June 2006
 30/06 Protherics, PiperJaffray/Vertex Pharmaceuticals/Samaritan, benzodiazepine receptor/PDS, software licensing/CRO, Phase I Read this newsletter
 28/06 Roche, Oncology/Asterand, Rubicon/Peakdale/Nalgene, flasks/Analytik Jena, China Read this newsletter
 26/06 Pharma, marketing practices/EntreMed, RA/Toxic plant, stroke/Applied Biosystems, LightSight/LabConnect, Synevo Read this newsletter
 23/06 Leukaemia trigger/QPS CRO services/Novozymes, Delta Bio/Odyessa Thera, patent/Fish, drug resistance Read this newsletter
 21/06 Odyessa Thera, Patent/fish farming, resistance/GSK, Cytokinetics/Pliva, India/Vical, avain flu Read this newsletter
 19/06 Spain, ape rights/Asthma drug, genes/Transcription factors/Teva, CureTech/Melbourn Scientific Read this newsletter
 16/06 Read this newsletter
 14/06 Galapagos, DPI/Cambrex, Cytori/Invitrogen, Solexa/Anachem, Recycling/Tripos, Benchware Read this newsletter
 12/06 Invitrogen,Scotland/protein factory/oestrogen receptor/PerkinElmer,assays/Velocity11,grips Read this newsletter
 09/06 BTG / Fortunes/AstraZeneca, Pipeline/New drug class, HIV/Applied Biosystems, microRNA/Epistem, IHC Read this newsletter
 07/06 BTG/Biovitrum/breast cancer drug/proteins/Genevac Read this newsletter
 05/06 Apes, animal testing/deltaBOT, DNA sequencing/R&D resources/Pall, Proteomics/SAFC, Proligo reagents Read this newsletter
 02/06 Stem cell/Novartis/Thermo, Galileo LIMS/AstraZeneca/drug screening Read this newsletter

May 2006
 31/05 AstraZeneca/GI market/Sigma-Aldrich/EU CNS market/New drug screening technique Read this newsletter
 26/05 EU, CNS market/Reverse screening/Cisbio, GPCR/Accium, Quintiles/Microbia, constipation Read this newsletter
 24/05 CAT,Humira/GE Healthcare, MDS Pharma/Laureate, Seattle Genetics/Abraxis, SPARC/Perbio, protein binding Read this newsletter
 22/05 WHO, Trial registration/marine-derived drugs/Biophage, immunotoxicity/tumour suppression,chemotherapy/sorbents, chromatography Read this newsletter
 19/05 Merck, first-in-class/Oxford University, injunction/gold, antisense drugs/NeoTropix, FDA approval/Patent, drug model Read this newsletter
 17/05 Blair, Animal testing/deCODE, outsourcing/GlycoFi, Merck/Berthold, Analytica/Decision News, award Read this newsletter
 15/05 HIV-SARS, secrets/Drugmaking, generalised fit/Nikon, microscope/RNAi, tumours/SAFC, insulin Read this newsletter
 11/05 Pharma-biotech collaboration/High Court, GSK/Clinical outsourcing/Agilent, HPLC/sugar, cell communication Read this newsletter
 09/05 Thermo, Fisher king/Animal rights, GSK/pharmacogenomic benefits/drug candidates/MesoPhotonics, SERS toolkit Read this newsletter
 04/05 G-protein modification/mice tests/PPD, PDL BioPharma/CyBio, Analytica/Analytica, Leica Read this newsletter
 02/05 Bruker BioSpin/Ilypsa/Perbio Science/Covance/Greiner Bio-One Read this newsletter

April 2006
 27/04 Drug development/cancer drug, bird flu/Endocyte, folate/Merck, RNA/Natural Pharmatech Read this newsletter
 26/04 Chronic illnesses/CEL-SCI, US Navy/MDS, myeloma/Thermo/Guava Tech Read this newsletter
 24/04 Schizophrenia gene/target-seeking molecule/Polymer Labs/iron-metabolising enzyme/Reaxa Read this newsletter
 20/04 Animal research/Bertin, launch/contract services/Smithers Group, Rapra/gene mutation, cholesterol control Read this newsletter
 18/04 Stem cell usage/Reata, drug agreement/brain tumour growth/Dowpharma, Pfenex Technology/ESA Biosciences, HPLC Read this newsletter
 13/04 Sigma-Aldrich/Olympus, screening/OGeS, Oxford Uni/Ablynx, P&G/drug development Read this newsletter
 11/04 Drug firms, disease/Olympus/Melbourn Scientific, expansion/Beckman, antibody/VASTox, cancer Read this newsletter
 06/04 Tapestry, cancer compound/MHRA, Parexel/Eden, Onyvax/biotech industry, profits/Wyatt, MALS Detector range Read this newsletter
 04/04 Light therapy, MRSA/Nastech, RNAi/inflammatory treatment/colorectal cancer/assay uptake Read this newsletter

March 2006
 30/03 Drug R&D/ExonHit/Upstate, Cisbio/HIV protein/Agilent Read this newsletter
 28/03 Brain development/diabetes/Affymetrix/Covalent Group/SARS drugs Read this newsletter
 23/03 Pharma market, study/plant-based technology/Vertex, CFFT/animal testing/BioTrove, Blue Sky Read this newsletter
 21/03 Parexel, trial/NicOx, Merck/Tripos, Abbott/brain disorder, drugs/Shimadzu, spectrometer Read this newsletter
 16/03 Parexel, drug trial/Thermo, Quickscan/Bayer Healthcare, Genedata/disease risks/ChemAxon, FMC Read this newsletter
 14/03 Schering, Merck/Kreatech, launch/anti-cancer drugs/menthol, new therapies/Bruker Daltonics, molecular imager Read this newsletter
 09/03 VGX, Dowpharma/Chemicon, SCS/FEI, Sidec/Huntington’s disease, research/Nucryst, patent Read this newsletter
 07/03 EU drug approval/protein receptor/velocity11/TB treatments/Agilent, assay kits Read this newsletter
 02/03 T-cell stimulation/DNA recognition/Nastech, Galenea/AGTC/GE Healthcare Read this newsletter

February 2006
 28/02 Drug collaboration/Rigel, study/new drug, TB/Abbott, Celera/Isis, Rosetta Read this newsletter
 23/02 eClinical trials/protein molecule/Thermo/Biofusion/new research Read this newsletter
 21/02 Novartis, Alnylam/wine compound/Ark breakthrough/Ceragenix/Asynt, parallel reactor Read this newsletter
 16/02 Rheumatoid arthritis/new ReactArray Solo/Honeywell/Singapore MTI/SIPLAS Read this newsletter
 14/02 Phoqus, Phase 1/Arpida, Phase 1/Genospectra, Sigma/Amgen, Biovitrum/Waters Read this newsletter
 09/02 Glaxo, 4Q/pharma research applications/antibiotic, drug resistance/Novascreen/Supelco, HPLC column Read this newsletter
 07/02 Evotec, Phase 1/Molecular Devices, IMAC detection system/drug-acedemia deal/liquid handlers/Affymetrix, Iconix Read this newsletter
 02/02 Amgen, facilities/SurModics, Donaldson Company/animal extremist, law/GE Healthcare/automation, integration Read this newsletter

January 2006
 31/01 Xceleron, microdose programme/Sanofi, 4Q/Pharmion, cancer drug deal/custom-designed enzymes/Ingenuity systems Read this newsletter
 26/01 Roche, Amira/HIV/Biovitrum/Scienion/Biochips price Read this newsletter
 24/01 Phosphagenics, animal trials/Immupharma, AIM/VASTox, DMD/Thermo, HCS technology/Oxford Immunotec, TB test Read this newsletter
 19/01 MerLion, NITD/Beckman, Biomek/Varian, SPE formats/Enanta Pharma, macrolide/supressor gene Read this newsletter
 17/01 Vertex, CFFT/Lipoxen, AIM/Lonza, peptide capacity/Boehringer, Evotec/Genevac, next-gen evaporator Read this newsletter
 12/01 Computational tools/Sigma, purification column/protein, inflammatory treatment/Cyprotex, PAMPA service/viral 'fitness', AIDS drugs Read this newsletter
 10/01 New drug, nerve repair/Pfizer, Sangamo/Scynexis Europe, Selcia/NanoDrop, spectrophotometer/Velocity11, Elisa Read this newsletter
 05/01 PCR patent expiry/CRO, Anthrax therapy/Genzyme, gene therapy/CRO, patient trials/New therapeutic targets Read this newsletter
 03/01 Genome discovery/Penicillin, Amoxicillin/bitter drugs/nanotechnology/Crucell Read this newsletter

December 2005
 22/12 Breast cancer therapeutics/Wyeth, facility/BioGenetics Capital, Clinquest Group/new microarray sequencer/Thermo, LIMS Read this newsletter
 20/12 Interscience Conference/DOV, depression drug/ISO, photometric method/Cresset, ion channel discovery tool/Tripos streamlining Read this newsletter
 15/12 La Jolla, SSAO/outsourcing spending/Roche, diabetes drug discovery/MiraiBio, Luminex platform/Accentia, chronic sinusitis test Read this newsletter
 13/12 Eli Lilly, 2006 outlook/Parkinson's, eye implants/CuraGen, TopoTarget/Solexa, Analyser/Thermo, crystallisation machine Read this newsletter
 08/12 Pharma industry/Phoqus, Circadian drug/Invitrogen, biotech/Clontech, TALON range/GE, histidine-tagged protein Read this newsletter
 06/12 BMS, T-cell stimulation/cancer drug resistance/drug target molecule/Stratagene, diagnostic market/Advaxis, dairy based vaccine Read this newsletter
 01/12 Animal lab construction/biopharmaceutical products/Roche, BioCryst/Gentra Systems, pharmacogenomics kit/neuroprotective drug Read this newsletter

November 2005
 29/11 Firms, outsourcing/Cellectricon, new chip/Richter, Forest Labs/SemBioSys, plant produced insulin/Bayer, immunoassay system Read this newsletter
 24/11 Gene therapy/new oncology drugs/Accentus, patented drugs/motion protein/Bio-Rad Labs, Applied Biosystems Read this newsletter
 22/11 Cell signalling/F&S, data/chemical Alzheimer's protection/Pfizer, Incyte/ZirChrom, chiral chromatography products Read this newsletter
 17/11 ABPI, pharma industry/Vasogen's drug/EU generics/Schering-Plough, OMS/Millipore, protein containing solutions Read this newsletter
 15/11 FLT-1, cancer/TorreyPines Therapeutics/pharma analytical tools/Aptuit, InfroPro Solutions/Kreatech, RNA kit Read this newsletter
 10/11 Varian/Nikon/Evotec/Sophion/Cyclacel Read this newsletter
 08/11 Biochip technology/HIV diagnostic test/GSK, Xceleron/Alzheimer's drug, Phase I/animal testing Read this newsletter
 03/11 Frogs, HIV/cytometry/gene discovery/HDL, immunity/breast cancer Read this newsletter
 01/11 Pharma, biotech, finances/cancer diagnostics/Viscotek, launch/cancer cell communication/Simulations Plus, ADMET Predictor Read this newsletter

October 2005
 27/10 Individualised drug therapies/F&S, pharmacogenomic diagnostics/Biolex, Kringle/DNA enzyme/Agilent, microarray Read this newsletter
 25/10 Animal research/Sigma-Aldrich, RNAi/melatonergic antidepressant/Serono, Rebif/Medisyn, natural compound Read this newsletter
 20/10 Antibacterial resistance/Bionovo, hormone therapy/pharma companies, trust/Dharmacon, Alcon/Research Dynamics, CRO Read this newsletter
 18/10 Roche, Epitomics/HIV protease inhibitor/regenerative medicine/Olympus, cell imaging/New Life, CureLab Read this newsletter
 13/10 Seaweed compounds, HIV/new antibiotic, superbugs/cancer virus, human cells/protein, drug delivery/Guava, cell screening Read this newsletter
 11/10 Diabetes drug, breakthrough/Roche, HIV/life sciences, funding/bone drug candidate/new gene therapy, PKU Read this newsletter
 07/10 Invitrogen, nanotechnology/rapid Abs/Alzheimer diagnosis/Strep vaccine/Biotage, distribution Read this newsletter
 05/10 Lab regulations/MerLion, Astellas/microarray hybridisation stations/Anthrax drug/arthritis, protein Read this newsletter
 03/10 Stem cells, diagnostic tool/new immune cell/'cure all' drug prospect/Angiotech, CombinatoRx/Integra, petri dish filler Read this newsletter

<
September 2005
 30/09 new receptor/animal activists/microarray market/weakening AIDS virus/S R Pharma, SiRNA Read this newsletter
 28/09 Celtic Pharma/DNA chips/IVD market/Olympus, imaging system/Decision News Media Read this newsletter